Shiue-Cheng Tang, Ph.D. - Publications
Affiliations: | 2003 | Georgia Institute of Technology, Atlanta, GA |
Area:
Chemical Engineering, Molecular Biology, Biomedical Engineering| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2017 | Thulé PM, Lin Y, Jia D, Olson DE, Tang SC, Sambanis A. mRNA destabilization improves glycemic responsiveness of transcriptionally regulated hepatic insulin gene therapy in vitro and in vivo. The Journal of Gene Medicine. PMID 28181342 DOI: 10.1002/Jgm.2946 | 0.591 | |||
| 2005 | Tang SC, Sambanis A, Sibley E. Proteasome modulating agents induce rAAV2-mediated transgene expression in human intestinal epithelial cells. Biochemical and Biophysical Research Communications. 331: 1392-400. PMID 15883029 DOI: 10.1016/J.Bbrc.2005.03.245 | 0.516 | |||
| 2004 | Tang SC, Sambanis A. Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and co-culture models of human enteroendocrine L-cells and enterocytes. The Journal of Gene Medicine. 6: 1003-13. PMID 15352073 DOI: 10.1002/Jgm.587 | 0.613 | |||
| 2003 | Tang SC, Sambanis A. Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer. Biochemical and Biophysical Research Communications. 303: 645-52. PMID 12659868 DOI: 10.1016/S0006-291X(03)00399-1 | 0.631 | |||
| 2003 | Tang SC, Sambanis A. Preproinsulin mRNA engineering and its application to the regulation of insulin secretion from human hepatomas. Febs Letters. 537: 193-7. PMID 12606056 DOI: 10.1016/S0014-5793(03)00121-2 | 0.61 | |||
| 1992 | Tang S. Changes in plasma glucagon concentration in patients with diabetes mellitus and its clinical significance Zhonghua Yi Xue Za Zhi. 72: 222-224, 255. PMID 1327451 | 0.334 | |||
| Show low-probability matches. | |||||